Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $260.88 | 9 | 92.9% |
| Education | $20.00 | 1 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MannKind Corporation | $115.55 | 2 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $42.17 | 2 | $0 (2023) |
| BOSTON SCIENTIFIC CORPORATION | $26.15 | 1 | $0 (2018) |
| Novo Nordisk Inc | $24.36 | 1 | $0 (2023) |
| Abbott Laboratories | $23.24 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $21.40 | 1 | $0 (2019) |
| Amgen Inc. | $15.00 | 1 | $0 (2018) |
| Janssen Biotech, Inc. | $13.01 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $205.32 | 6 | MannKind Corporation ($115.55) |
| 2021 | $13.01 | 1 | Janssen Biotech, Inc. ($13.01) |
| 2019 | $21.40 | 1 | Sunovion Pharmaceuticals Inc. ($21.40) |
| 2018 | $41.15 | 2 | BOSTON SCIENTIFIC CORPORATION ($26.15) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2023 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/31/2023 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/05/2023 | MannKind Corporation | AFREZZA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: DIABETES MEDICINE | ||||||
| 07/28/2023 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $95.55 | General |
| Category: DIABETES MEDICINE | ||||||
| 03/10/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Heart Failure | ||||||
| 10/07/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Oncology | ||||||
| 07/18/2019 | Sunovion Pharmaceuticals Inc. | SEEBRI NEOHALER (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL VASCULAR INTERVENTION (Device) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: VASCULAR | ||||||
| 09/27/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 680 | 3,250 | $910,570 | $273,527 |
| 2022 | 5 | 550 | 2,169 | $550,876 | $173,705 |
| 2021 | 5 | 686 | 2,813 | $716,363 | $252,266 |
| 2020 | 7 | 948 | 4,021 | $1.1M | $352,792 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 126 | 1,370 | $421,640 | $131,331 | 31.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 185 | 1,450 | $309,051 | $92,655 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 188 | 219 | $112,877 | $30,017 | 26.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 181 | 211 | $67,001 | $19,524 | 29.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 1,139 | $307,530 | $93,962 | 30.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 114 | 694 | $126,490 | $39,761 | 31.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 140 | 161 | $70,035 | $25,527 | 36.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 146 | 164 | $44,280 | $13,816 | 31.2% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 11 | 11 | $2,541 | $638.58 | 25.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 196 | 1,931 | $486,495 | $166,173 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 192 | 245 | $99,135 | $40,216 | 40.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 87 | 392 | $67,383 | $23,407 | 34.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 194 | 228 | $57,260 | $20,097 | 35.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 17 | 17 | $6,090 | $2,374 | 39.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 280 | 2,822 | $691,390 | $230,510 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 263 | 307 | $121,265 | $47,741 | 39.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 252 | 289 | $70,805 | $23,852 | 33.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 11 | 132 | $88,440 | $22,874 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 93 | 417 | $68,805 | $22,837 | 33.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 26 | 28 | $9,800 | $3,512 | 35.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 23 | 26 | $5,460 | $1,466 | 26.9% |
About Dr. Stephen Koch, M.D
Dr. Stephen Koch, M.D is a Internal Medicine healthcare provider based in Deer Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750325601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Koch, M.D has received a total of $280.88 in payments from pharmaceutical and medical device companies, with $205.32 received in 2023. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($260.88).
As a Medicare-enrolled provider, Koch has provided services to 2,864 Medicare beneficiaries, totaling 12,253 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Deer Park, TX
- Active Since 06/15/2006
- Last Updated 02/25/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1750325601
Products in Payments
- AFREZZA (Drug) $115.55
- RECORLEV (Drug) $42.17
- GENERAL VASCULAR INTERVENTION (Device) $26.15
- Ozempic (Drug) $24.36
- CARDIOMEMS (Device) $23.24
- SEEBRI NEOHALER (Drug) $21.40
- Repatha (Biological) $15.00
- ERLEADA (Drug) $13.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Deer Park
Saiqa Iram, Md, MD
Internal Medicine — Payments: $532.37
Dr. Lora Jasman, M.d, M.D
Internal Medicine — Payments: $305.20
Dr. Sharmila Shah, Md,Mph, MD,MPH
Internal Medicine — Payments: $219.91
Michelle Signs, Do, DO
Internal Medicine — Payments: $50.45